Opioid Disorder

Almost one in 10 patients treated with prescription opioid painkillers experience opioid dependency or opioid use disorder, a result from a systematic review and meta-analysis showed.

More than six in 10 Americans were unaware that primary care providers can prescribe treatment for opioid use disorder, or OUD, according to survey results published in JAMA Network Open.

Few individuals received medications for opioid use disorder or filled a naloxone prescription after a nonfatal drug overdose, despite the benefits of these treatments in reducing the odds for a future fatal overdose, data show.

Less than half of pediatricians in the United States who responded to a survey said they felt prepared to counsel patients on opioid use disorder, researchers reported.

About 58% of pharmacies reported availability of buprenorphine for opioid use disorder at the time of patients’ requests, according to researchers.

A medication-assisted treatment, or MAT, supplemental training program improved primary care physicians’ confidence and willingness to implement MAT for opioid use disorder, a recent study found.

CHICAGO — With more than 1.5 million veterans diagnosed with headache over the past two decades, the Veterans Health Administration must improve outreach and care to address disparities, an expert said at ANA 2022.

Following the 2021 record-setting report of opioid overdose deaths in the United States, experts are predicting higher rates of overdose deaths, based on the results of a report published in JAMA Network Open.

Researchers have outlined consensus-based management strategies to guide clinicians who care for patients with cancer-associated pain and opioid misuse or opioid use disorder.

A multilevel program that provided support and resources to rural primary care practices was associated with an increase in buprenorphine prescriptions, data show.